|Event Date/Time: Mar 08, 2010||End Date/Time: Mar 10, 2010|
* Attend presentations by more than 350 speakers
* Hear representatives from the EMEA, FDA and regulatory agencies throughout Europe
* Attend preconference tutorials
* Network with professional colleagues from around the world
* Visit more than 200 exhibitors in Europeâ€™s largest interactive exhibit hall
* Choose from hot-topic sessions in 13 themes:
Theme 1: Innovation
Is an Open Innovation Paradigm the Way Forward for Pharma?
Theme 2: Staying in Business: How to Make Sure You Comply with All Rules and Regulations, Quality, Compliance, and External Challenges
The Price of Globalisation: Bringing Modern Therapies to Developing Countries or Only Including Patients in Trials? What Should We All Know About Indian Society, Medical Practice and Patients Before Drawing Conclusions?
Theme 3: Paediatric Medicines on Their Way to Patients
Initial Impact of the Paediatric Regulation After 3 Years
Theme 4: Decision Making: The Key to Efficient and Effective Drug Development, approval, and access
Influence of HTA on Regulatory Decision-Making: Reality? Opportunity? Threat?
Theme 5: Paving the Way for Advanced Therapies: Fostering New Generations of Biotechnology-Derived Medicines
CAT Experience in the First Year
Theme 6: Challenges for Switching from Prescription to Non-Prescription Status through the Centralised Procedure
Could the UK Model Be Reproduced at EU Level?
Theme 7: Personalised Medicines: What Is It, Where Do We Stand, and Where Are We Going?
The EMEAâ€™s New Biomarker Qualification Process: How Does It Work and Where Does It Fit?
Theme 8: Taking the European Regulatory Infrastructure Forward
Pharmaceutical Package - The Latest Information
Theme 9: Risk Management
Research Initiatives in Risk Management|
Theme 10: The Informed Patient
Pharmaceutical Package: Information to Patient Proposals - What Difference Will They Make?
Theme 11: eHealth
Connecting Healthcare and Clinical Research
Theme 12: Pharmaceutical Sciences in 2020
What Major Research Activities Will Drive Drug Discovery and Development?
Theme 13: Handling Clinical Trials, eSubmissions and Quality Requests
Emerging Standards from ICH